GlassScriptPhysician profile
Thomas Sam Nasser
NPI 1073594636
$4,754.96
in general payments reported to CMS, 2019-2025
20 companies · $895 in 2025
The $895 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $138 · 2021: $275 · 2022: $503 · 2023: $1,096 · 2024: $1,362 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,352.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,383.61 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Ascenda |
| Biotronik Nro, INC. | $791.19 | 2024-2025 | Prospera |
| Nevro Corp. | $752.36 | 2022-2024 | Senza |
| Abbott Laboratories | $592.41 | 2019-2024 | Proclaim, Octrode |
| Boston Scientific Corporation | $325.93 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $288.51 | 2022-2023 | Mild Device Kit |
| Daiichi Sankyo INC. | $157.32 | 2019 | |
| Abbvie INC. | $73.51 | 2022-2024 | |
| Allergan, INC. | $68.65 | 2020 | |
| Collegium Pharmaceutical, INC. | $57.72 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $44.55 | 2025 | |
| Globus Medical, INC. | $41.01 | 2025 | Vyrsa V1, Omnia |
| Medtronic USA, INC. | $33.41 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $28.41 | 2019 | |
| Microtransponder, INC. | $23.81 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $23.00 | 2019 | |
| Spinal Simplicity, LLC | $22.30 | 2025 | Ha Minuteman G3-R |
| Zimmer Biomet Holdings, INC. | $17.25 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Biodelivery Sciences International, INC. | $17.00 | 2019 | |
| Indivior INC. | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.